Second Quarter 2018 Financial Results. April 27, 2018
|
|
- Roger Foster
- 5 years ago
- Views:
Transcription
1 Second Quarter 2018 Financial Results April 27, 2018
2 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of All statements included herein that are not historical facts are forwardlooking statements, including without limitation statements regarding Hill-Rom s ability to drive sustainable profitable growth and shareholder value, the timing and success of new product launches and portfolio expansion, the ability to achieve the anticipated benefits of the Mortara acquisition, the achievement of long-range financial objectives, the continuation of stable customer demand trends, a stable U.S. capital environment, the timing and success of M&A and optimization initiatives (including the divestiture of our third-party rental business), our ability to reduce debt, the impact of the new U.S. tax reform legislation, and all other statements concerning future strategy, plans, objectives, projections, expectations and intentions. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Hill-Rom s results could be materially adversely affected. For a more in depth discussion of factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading Risk Factors in the company's previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Hill-Rom assumes no obligation to update or revise any forward-looking statements. Certain financial figures presented herein have been presented on an adjusted basis (non-gaap). Reconciliation between non-gaap financial measures and reported U.S. GAAP measures are included in the appendices to this slide deck. Page 2
3 Page 3
4 Q Highlights
5 Leadership $2.7B global medical technology leader with market-leading positions 2017 Revenue by Business US$ Billions Surgical Solutions Front Line Care $2.7B FY 2017 Patient Support Systems Innovation Advancing global scale and brand equity while enhancing outcomes Increased Investment in R&D US$ Millions 4.6% of revenue $92 4.9% of revenue $134 Value Transforming to drive sustainable profitable growth and shareholder value Key Valuation Metrics As of 3/31/2018 $5.8B $7.8B +24% Market Capitalization Enterprise Value LTM Total Shareholder Return Note: Hill-Rom fiscal year end is September $25M *Includes dividends YTD Fiscal 2018 Returned to Shareholders* Page 5
6 Accelerating growth by advancing strong brands and geographic footprint Driving commercial momentum and operational execution with Q2 core revenue* growth of 2% Establishing a diversified business to drive sustainable growth and profitability Innovating to enhance outcomes for patients and their caregivers Enhancing Spot Vision Screener for patients with up to 3 mm pupil sizes, a first-of-its-kind application; launching Bard Parker Plus Blade with Loader to enhance safety and sharps injuries Capitalizing on significant introductions such as Integrated Table Motion, Connex Spot Monitor, RetinaVue and Spot Vision Screener Transforming the portfolio with select M&A and optimization initiatives Integrating Mortara and divesting third-party rental business Optimizing product portfolio through completed divestitures and exit of non-strategic assets Driving operational execution and strong financial performance Delivering solid revenue growth, expanding margins and growing adjusted EPS by 19% to $1.05 Updating full-year adjusted EPS guidance to $4.60 to $4.65 per diluted share Enhancing Shareholder Value By Executing Our Strategy Page 6 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation *Core revenue excludes foreign currency, divestitures, exit of nonstrategic assets and Mortara prior to the anniversary date of the acquisition
7 Q Financial Summary
8 Revenue Operating Margin Earnings Per Share Operating Cash Flow 2% Core* Growth $711M $679M 15.0% +120 BPS $ % Growth Flat 16.2% $1.05 $126M $126M Q Q Q Q Q Q Q2 YTD 2017 Q2 YTD 2018 Delivering Solid Core Revenue And Exceeding Adjusted EPS Guidance Page 8 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; Axis not to scale *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets and Mortara prior to the anniversary date of the acquisition
9 Fiscal Second Quarter Adjusted P&L YOY Change Revenue $679M $711M +2% constant currency +2% core* growth Gross Margin 48.0% 49.3% +130 bps Operating Margin 15.0% 16.2% +120 bps Adjusted EPS $0.88 $ % Driving 11 th Consecutive Quarter Of Double-Digit Adjusted EPS Growth Page 9 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; Axis not to scale *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets and Mortara prior to the anniversary date of the acquisition
10 Patient Support Systems Front Line Care Surgical Solutions Q YTD 2018 Q YTD 2018 Q YTD 2018 Building momentum with new products like Centrella, Envella and Accella Meeting large customer demand for CWS with double-digit growth Continuing international momentum in Middle East, Latin America and Canada Optimizing product portfolio, exiting lowermargin businesses Driving revenue acceleration with recent product introductions Growing thermometry, blood pressure and physical assessment revenue Delivering strong core international growth with One Hill-Rom approach Driving 10%+ growth in Respiratory Care Continuing solid Integrated Table Motion adoption Maintaining strong international growth momentum Enhancing safety and easeof-use with new products and upgrades Advancing innovation and partnerships to drive future growth Note: All revenue growth rates are constant currency *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets and Mortara prior to the anniversary date of the acquisition Page 10
11 Adjusted Gross Margin Adjusted Operating Margin +100 bps +30 bps +130 bps (10) bps 48.0% 49.3% 15.0% 16.2% Q Portfolio Optimization Operational Efficiencies Q Q GM Expansion Opex Leverage Q bps Gross Margin Expansion +120 bps Operating Margin Expansion Expanding Margins With New Products, Portfolio Diversification And Ongoing Optimization Initiatives Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; Axis not to scale Page 11
12 Solid core revenue* growth of 2% Positive contribution from new products, portfolio diversification and operational efficiencies Enhancing global commercial capabilities by investing in new products and strategic initiatives Realizing benefit from U.S. tax reform legislation Adjusted EPS Growth US$ $ % growth $1.05 $1.05 Adjusted Earnings Per Diluted Share Q Q Exceeding Expectations With +19% Adjusted EPS Growth Page 12 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation *Core revenue excludes foreign currency, divestitures, exit of nonstrategic assets and Mortara prior to the anniversary date of the acquisition
13 Cash Flow US$ Millions $126 $126 Operating Cash Flow $79 Q2 YTD 2017 Q2 YTD 2018 $74 Free Cash Flow Capital Allocation Priorities Reducing debt levels Re-investing in business (R&D and CapEx) Raising quarterly dividend Executing disciplined M&A strategy emphasizing: Accelerated growth with diversified revenue streams and accretive P&L profile Products and services that strengthen clinical and economic value with customers ~4.0x ~3.2x* 2017 Leverage 2018 Leverage Enhancing Financial Flexibility With Strong Cash Flow Generation Note: Leverage calculated as Total Debt divided by EBITDA as defined in Hill-Rom s compliance certificate *Assumes no further M&A activity Page 13
14 2018 Financial Outlook
15 ~3% Core Revenue Growth* ~100 bps Operating Margin Expansion 19% - 20% Growth in Adjusted EPS Adjusted P&L 2018 Prior Outlook 2018 Current Outlook Revenue Growth (reported) 3% - 4% 3% - 4% Gross Margin +50 bps +75 bps Operating Margin +100 bps +100 bps Adjusted EPS $ $4.65 $ $4.65 Operating Cash Flow ~$350M ~$350M Capital Expenditures ~$110M ~$110M Driving Strong Adjusted Earnings And Cash Flow Growth Page 15 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets and Mortara prior to the anniversary date of the acquisition
16 2018 Revenue Growth Outlook 2018 Revenue Growth Constant Core* Patient Support Systems Decline Low- Single Digits Low-Single Digits ~3% 3% - 4% Front Line Care High-Single Digits Low-to-Mid Single Digits 2% - 3% Surgical Solutions Low-to-Mid Single Digits Total Hill-Rom 2% - 3% ~3% Core Revenue* Mortara Non-Strategic Constant Currency FX Reported Revenue Delivering Solid 2018 Core Revenue Growth Of ~3% Note: All growth rates are constant currency *Core revenue excludes foreign currency, divestitures, exit of nonstrategic assets and Mortara prior to the anniversary date of the acquisition Page 16
17 Adjusted P&L Q Outlook Q Outlook Reflects: Accelerating core revenue momentum and benefit from new products Revenue Growth ~3% Reported Anticipating higher margins in 2H: Higher revenue Revenue Growth ~1% Constant 3% - 4% Core* Improved surgical margins Mortara synergy benefits Adjusted EPS $ $1.14 Cost and business optimization initiatives savings Executing on strategic initiatives Accelerating Core Revenue Growth While Investing In Key Strategic Growth Initiatives *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets and Mortara prior to the anniversary date of the acquisition Page 17
18 Revenue Schedules
19 Page 19
20 Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 86.8 $ $ $ $ % -13.5% -1.9% 2.9% -10.7% -1.1% Front Line Care % -16.9% -8.4% -4.8% -15.7% -8.0% Surgical Solutions % -8.3% 1.1% 12.9% -4.5% 3.2% Total Hill-Rom $ $ $ $ $ $ % -13.2% -3.6% 1.2% -10.6% -2.7% Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 99.8 $ $ $ 93.8 $ % 6.4% 3.0% 1.8% 9.2% 3.8% Front Line Care % 20.7% 13.9% 11.1% 22.8% 14.5% Surgical Solutions % 8.8% 10.4% 12.2% 12.6% 12.4% Total Hill-Rom $ $ $ $ $ $ % 10.9% 7.3% 5.7% 13.7% 8.2% Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 99.7 $ $ $ $ % -2.5% -1.7% -1.4% -0.2% -1.1% Front Line Care % 20.2% 17.9% 17.0% 23.6% 18.8% Surgical Solutions % 9.4% 5.5% 1.6% 12.4% 7.0% Total Hill-Rom $ $ $ $ $ $ % 6.3% 5.1% 4.6% 9.0% 6.0% Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 97.9 $ $ $ $ % -5.3% -2.9% -2.0% -8.7% -3.8% Front Line Care % 33.9% 16.0% 10.0% 31.8% 15.5% Surgical Solutions % 4.8% 8.6% 12.3% 0.9% 6.6% Total Hill-Rom $ $ $ $ $ $ % 7.1% 4.6% 3.5% 4.0% 3.6% Fiscal Year 2017 Fiscal Year 2016 % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ 1,039.7 $ $ 1,423.9 $ 1,037.4 $ $ 1, % -3.9% -0.9% 0.2% -2.8% -0.6% Front Line Care % 12.8% 9.3% 8.0% 14.0% 9.7% Surgical Solutions % 3.4% 6.4% 9.6% 5.0% 7.2% Total Hill-Rom $ 1,887.6 $ $ 2,743.7 $ 1,819.5 $ $ 2, % 2.4% 3.3% 3.7% 3.7% 3.7% Note: Segment revenue by U.S. and International for Fiscal Year ended 9/30/2017 and 9/30/2016 in US$ million; Certain revenue amounts have been reclassified for Surgical Solutions between U.S. and International to more accurately align with the destination of the revenue and to be consistent with the 2018 Page 20 presentation. These changes do not have a significant impact in comparison to previously reported amounts and growth rates
21 Appendix Reconciliations Of Non-GAAP Disclosures
22 Quarter Ended March 31 US OUS As Constant As As Constant Reported Currency Reported Reported Currency Product Sales and Service $ $ % 2.2% 1.1% 13.0% 4.1% Rental % (0.8%) 0.1% 3.6% (8.0%) Total $ $ % 1.8% 1.0% 12.5% 3.5% US OUS As Constant As As Constant Reported Currency Reported Reported Currency Patient Support Systems $ $ (2.2%) (4.5%) (5.5%) 6.5% (2.0%) Front Line Care % 10.7% 10.9% 17.0% 10.1% Surgical Solutions % 5.6% 5.4% 18.4% 5.8% Total % 1.8% 1.0% 12.5% 3.5% $ - $ - $ - $ (0.0) $ (0.0) $ 0.0 $ 0.0 Year to Date Ended March 31 US OUS As Constant As As Constant Reported Currency Reported Reported Currency Product Sales and Service $ 1,185.9 $ 1, % 3.0% 1.7% 13.4% 5.5% Rental (0.3%) (1.3%) (0.8%) 4.1% (5.5%) Total $ 1,380.2 $ 1, % 2.4% 1.2% 12.9% 4.9% US OUS As Constant As As Constant Reported Currency Reported Reported Currency Patient Support Systems $ $ (1.2%) (3.3%) (3.8%) 5.6% (2.0%) Front Line Care % 10.2% 9.0% 19.6% 13.3% Surgical Solutions % 5.7% 3.6% 18.5% 7.7% Total $ 1,380.2 $ 1, % 2.4% 1.2% 12.9% 4.9% Page 22
23 ($ in millions) Quarter Ended March 31 Year To Date Ended March Selling and Administrative Expenses (As Reported) $ $ $ $ Acquisition and integration costs (2.6) (6.3) (5.0) $ (12.2) Acquisition-related intangible asset amortization (27.0) (26.6) (53.7) $ (52.1) Litigation expenses (1.8) (0.9) (5.8) (0.9) Tax method and law changes and related costs (0.8) - (0.8) - Selling and Administrative Expenses (Adjusted) $ $ $ $ Selling and Administrative Expenses (Adjusted) As Percent of Total Revenue 28.2% 27.8% 28.2% 27.8% Year Over Year % Change 6.3% 6.3% Year Over Year Change 40 bps 40 bps Page 23
24 Gross Margin Quarter Ended March 31, 2018 Income Before Income Taxes Operating Margin Income Tax Expense Diluted EPS Gross Margin Quarter Ended March 31, 2017 Income Before Operating Margin 1 Income Taxes Income Tax Expense Diluted EPS 1 GAAP Basis 49.3% 6.5% $ 21.5 $ (7.0) $ % 9.4% $ 41.3 $ 7.3 $ 0.51 Adjustments: Acquisition and integration costs - 0.4% % 1.1% Acquisition-related intangible asset amortization - 3.8% % Field corrective actions % 0.1% 0.5 (0.1) 0.01 Litigation expenses - 0.3% % 0.1% Special charges - 5.2% % Tax method and law changes and related costs (0.12) 0.0% Adjusted Basis 49.3% 16.2% $ 90.6 $ 19.4 $ % 15.0% $ 79.6 $ 20.8 $ Total does not add due to rounding. Gross Margin Year to Date Ended March 31, 2018 Income Before Operating Margin Income Taxes Income Tax Expense Diluted EPS Gross Margin Year to Date Ended March 31, 2017 Income Before Operating Margin 1 Income Taxes Income Tax Expense Diluted EPS GAAP Basis 48.5% 7.1% $ 52.3 $ (64.5) $ % 9.1% $ 76.6 $ 19.1 $ 0.87 Adjustments: Acquisition and integration costs - 0.4% % 1.0% Acquisition-related intangible asset amortization - 3.9% % Field corrective actions (0.1) 0.01 Litigation expenses - 0.4% % Special charges - 3.7% % Tax method and law changes and related costs (1.01) (2.2) 0.03 Gain on disposition - - (1.0) - (0.01) - - (1.0) (0.4) (0.01) Adjusted Basis 48.5% 15.5% $ $ 34.0 $ % 14.8% $ $ 42.4 $ Total does not add due to rounding. Page 24
25 Appendix Other Supplementary Schedules
26 Centrella SmartBed System Connex Spot Monitor Improving patient safety and satisfaction with enhanced features, minimizing the risk of falls Providing solutions that improve clinical outcomes and patient safety Enhancing caregiver features for quick and easy updates, such as integrating with NaviCare Patient Safety applications Meeting customers evolving needs by creating a scalable platform Advancing care in acute settings with highly configurable early warning score protocols Increasing efficiency with wireless connectivity to 100+ EMRs and an easy-to-use interface U.S. Average Bed Lifespan U.S. MedSurg Portion Of Installed Beds Global MedSurg Market # Of Minutes To Scan All Vitals Within Acute Care Settings U.S. Automated Vitals Market Page 26
27 Spot Vision Screener RetinaVue Network Screening for diseases that impair vision Increasing efficiency with testing in seconds Delivering an objective and consistent approach to vision screenings across care settings Expanding to 3 mm pupil size to address needs of aging populations Detecting preventable blindness with simple and convenient diabetic retinopathy screening Enabling diabetic retinopathy exams in primary care settings Increasing compliance of diabetic retinopathy exams, currently only 50% Children With Vision Disorders Children Screened Prior To Kindergarten U.S. Market Potential Americans With Diabetes Contract Diabetic Retinopathy Recurring Revenue U.S. Market Potential Page 27
28 Welch Allyn Home Hypertension Monarch Airway Clearance System Delivering clinically accurate connected blood pressure device for home use Elevating patient quality-of-life with portable, Bluetooth enabled vest Enabling patients to track and communicate readings with mobile applications Increasing therapy compliance with increased flexibility from mobility freedom Incorporating a free and cloud-based system to ease clinician's review of data Enhancing connected care discussions and early interventions via connectivity options Trusted Device Patient Application Clinical Portal U.S. Blood Pressure Devices Sold Annually U.S. Physician Offices U.S. Existing Market U.S. Cystic Fibrosis Patients U.S. Bronchiectasis Patients U.S. HRCWO Market Page 28
29 Integrated Table Motion iled 7 Surgical Light Delivering seamless system for table adjustments during robotic-assisted surgical procedures Optimizing the lighting environment at all times during surgery Enhancing safety and efficiency in the operating room Improving safety and efficiency by eliminating the need for manual lighting adjustments Incorporating technology to improve hospital efficiency and information flow Driving innovation with streamlined design and options for additional integration features U.S. Acute Care Operating Rooms Annual Market Growth Rate Global Surgical Equipment Market Page 29
30 ($ in millions) Revenue Q Q2 YTD 2018 Rev. Growth CC Growth Revenue Rev. Growth CC Growth Other PSS U.S. $248.7 (5.5%) (5.5%) $492.3 (3.8%) (3.8%) OUS $ % (2.0%) $ % (2.0%) Total $355.0 (2.2%) (4.5%) $689.4 (1.2%) (3.3%) CWS & Patient Handling $1,424M FY 2017 Rental & Service MedSurg Beds Specialty Beds Frames & Surfaces Clinical Workflow Solutions Patient Handling Diversified Portfolio Drives Stable, Long-Term Growth Page 30
31 ($ in millions) Q Q2 YTD 2018 Revenue Rev. Growth CC Growth Revenue Rev. Growth CC Growth U.S. $ % +10.9% $ % +9.0% OUS $ % +10.1% $ % +13.3% Total $ % +10.7% $ % +10.2% Respiratory Other FLC $885M FY 2017 Thermome try & Blood Pressure Physical Assessment Vital Signs Physical Assessment Vital Signs Respiratory Care Significant Opportunity To Drive Commercial Value And Innovation Page 31
32 ($ in millions) Q Q2 YTD 2018 Revenue Rev. Growth CC Growth Revenue Rev. Growth CC Growth Blades & Scalpels U.S. $ % +5.4% $ % +3.6% OUS $ % +5.8% $ % +7.7% Total $ % +5.6% $ % +5.7% Other OR Consumables $435M FY 2017 OR Tables & Lights Patient Positioning OR Booms, Pendants & Other Operating Tables Operating Lights Consumables Accelerating Long-Term Global Growth Of Strong, Innovative Portfolio Page 32
Third Quarter 2018 Financial Results. July 27, 2018
Third Quarter 2018 Financial Results July 27, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationFirst Quarter 2018 Financial Results. January 26, 2018
First Quarter 2018 Financial Results January 26, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationUBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017
UBS Healthcare Conference John J. Greisch, President and CEO May 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, within the meaning of the Private Securities
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference John J. Greisch, President and CEO January 9, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform
More informationADVANCING CONNECTED CARE
ADVANCING CONNECTED CARE J.P. Morgan Healthcare Conference John Groetelaars, President and CEO January 8, 2019 Forward looking statements and non-gaap financial measures This presentation contains forward-looking
More informationHill-Rom Reports Strong Fiscal Third Quarter 2018 Financial Results
NEWS RELEASE Hill-Rom Reports Strong Fiscal Third Quarter 2018 Financial Results 7/27/2018 New Products and Operational Execution Drive Revenue and Margin Expansion; Core Revenue Growth Accelerates Company
More informationMedia Howard Karesh, Vice President, Corporate Communications Phone:
CONTACT INFORMATION Investor Relations Contact: Mary Kay Ladone, Vice President, Investor Relations Phone: 312-819-9387 Email: MaryKay.Ladone@hill-rom.com Media Contact: Howard Karesh, Vice President,
More informationHill-Rom Highlights Long-Term Strategic And Financial Objectives
NEWS RELEASE Hill-Rom Highlights Long-Term Strategic And Financial Objectives 11/3/2017 2020 Outlook Reflects Value of Diversification and Innovation, Portfolio and Business Optimization Initiatives, and
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO
J.P. MORGAN HEALTHCARE CONFERENCE Robert Abernathy Chairman and CEO OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and conference call, including our 2016 outlook, expectations
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Joe Woody Chief Executive Officer
J.P. MORGAN HEALTHCARE CONFERENCE Joe Woody Chief Executive Officer 0 OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and webcast, including our outlook, expectations and planning
More informationFOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook and Update on Divestiture 2018 Priorities Steve Voskuil Chief Financial Officer
More informationZEBRA TECHNOLOGIES FIRST QUARTER 2016 RESULTS May 10, 2016
ZEBRA TECHNOLOGIES FIRST QUARTER 2016 RESULTS May 10, 2016 Anders Gustafsson Chief Executive Officer Mike Smiley Chief Financial Officer 2 Safe Harbor Statement Statements made in this presentation which
More informationFOURTH QUARTER 2015 EARNINGS CALL. February 29, 2016
FOURTH QUARTER 2015 EARNINGS CALL February 29, 2016 FOURTH QUARTER EARNINGS CALL AGENDA Fourth Quarter Update Robert Abernathy, Chairman and Chief Executive Officer Fourth Quarter Results and 2016 Outlook
More informationFirst Quarter 2017 Conference Call
First Quarter 2017 Conference Call May 4, 2017 research technology consulting Forward-Looking Statements and Non-GAAP Presentation 2 This presentation contains forward-looking statements within the meaning
More informationJefferies 2014 Global Healthcare Conference
Jefferies 2014 Global Healthcare Conference June 4 th, 2014 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. This includes
More informationFIRST QUARTER 2018 EARNINGS CALL MAY 2, 2018
FIRST QUARTER 2018 EARNINGS CALL MAY 2, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook Update on 2018 Priorities Steve Voskuil Chief Financial Officer First Quarter Financial
More informationSECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017
SECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017 SECOND QUARTER EARNINGS CALL AGENDA CEO Transition Robert Abernathy Chairman Strategic Vision Joe Woody Chief Executive Officer Second Quarter Results and
More informationTransUnion. Investor Presentation
TransUnion Investor Presentation APRIL 2017 Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements
More informationWatts Water Technologies 4Q and FY 2017 Earnings Conference Call
Watts Water Technologies 4Q and FY 2017 Earnings Conference Call February 13, 2018 Forward Looking Statements Certain statements in this presentation constitute forward-looking statements within the meaning
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Healthcare Conference, September 2017 NASDAQ: NOVT 1 Safe Harbor Statement The statements in this presentation
More informationWatts Water Technologies 3Q 2017 Earnings Conference Call November 2, 2017
Watts Water Technologies 3Q 2017 Earnings Conference Call November 2, 2017 2017 Watts Water Technologies, Inc. Forward Looking Statements Certain statements in this presentation constitute forward-looking
More informationFourth Quarter Fiscal Year 2017
Fourth Quarter Fiscal Year 2017 October 25, 2017 J. Michael Bruff Vice President Investor Relations Mike.Bruff@Varian.com This presentation is intended exclusively for investors. It is not intended for
More information1st Quarter 2018 Earnings Conference Call. April 24, 2018
1st Quarter 2018 Earnings Conference Call April 24, 2018 Forward-looking statements During this presentation, we make certain forward-looking statements concerning plans and expectations for Carlisle Companies
More informationQ3 Fiscal Year 2016 Financial Results January 20, 2016
Q3 Fiscal Year 2016 Financial Results January 20, 2016 FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of the federal securities laws, including, without
More informationPTC SECOND QUARTER FISCAL 2017 PREPARED REMARKS APRIL 19, 2017
PTC SECOND QUARTER FISCAL 2017 PREPARED REMARKS APRIL 19, 2017 Please refer to the Important Disclosures section of these prepared remarks for important information about our operating metrics (including
More informationQuarterly Investor Presentation. First Quarter 2017
Quarterly Investor Presentation First Quarter 2017 Forward Looking Statements This presentation contains statements about future events and expectations that constitute forward looking statements. These
More information2Q 2017 Highlights and Operating Results
2Q 2017 Highlights and Operating Results July 25, 2017 1 2Q 2017 Highlights and Operating Results Table of Contents Page(s) 1 Sales Overview and Highlights 4-5 2 NSS Overview 6-7 3 EES Overview 8-9 4 UPS
More information4Q 2018 Highlights and Operating Results. Products. Technology. Services. Delivered Globally.
4Q 2018 Highlights and Operating Results Products. Technology. Services. Delivered Globally. Table of Contents Page 3 Safe Harbor Statement and Non-GAAP Financial Measures 4 Sales Overview 9 Overview of
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Industrial Conference, November 2017 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION NOTES TO INVESTORS FORWARD-LOOKING STATEMENTS. These materials contain forward-looking statements. Statements that describe or relate to NCR's plans, goals, intentions, strategies,
More informationJP Morgan Healthcare Conference January 13, 2016
JP Morgan Healthcare Conference January 13, 2016 FORWARD-LOOKING STATEMENTS Certain statements and information in this presentation may be deemed to be forward-looking statements within the meaning of
More informationIBM 1Q 2018 Earnings. April 17, ibm.com/investor
IBM 1Q 2018 Earnings April 17, 2018 ibm.com/investor Forward Looking Statements and Non-GAAP Information 2 Certain comments made in this presentation may be characterized as forward looking under the Private
More informationINVESTOR PRESENTATION MAY 2018
INVESTOR PRESENTATION MAY 2018 Forward-Looking Statements Forward-Looking Statements This presentation and other written or oral statements made from time to time by representatives of Broadridge Financial
More informationInvestment Community Conference Call
DieboldNixdorf.com Investment Community Conference Call Second Quarter, 2018 Earnings August 1, 2018 Use of Non-GAAP Financial Information To supplement our condensed consolidated financial statements
More information3 RD QUARTER 2013 RESULTS CONFERENCE CALL & WEBCAST
3 RD QUARTER 2013 RESULTS CONFERENCE CALL & WEBCAST OCTOBER 23, 2013 8:30AM ET / 2:30PM CET NYSE: NLSN SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS The following discussion contains forward-looking statements,
More informationRoyal Bank of Canada Second Quarter Results May 24, 2018
Royal Bank of Canada Second Quarter Results May 24, 2018 All amounts are in Canadian dollars unless otherwise indicated and are based on financial statements prepared in compliance with International Accounting
More informationDriving Profitable Growth
Driving Profitable Growth Frank Calderoni EVP and Chief Financial Officer December 7, 2012 Forward-Looking Statements This presentation contains projections and other forward-looking statements regarding
More information2018 FOURTH QUARTER EARNINGS CALL
NORTH AMERICA S LEADING BUILDING MATERIALS DISTRIBUTOR RESIDENTIAL COMMERCIAL INTERIOR SOLAR 2018 FOURTH QUARTER EARNINGS CALL Forward Looking Statements / Non-GAAP Measures This presentation contains
More informationQ Earnings Call February 20, 2019
Q4 2018 Earnings Call February 20, 2019 1 Forward-looking statements Safe Harbor Statement This release contains forward-looking statements, which may concern our plans, objectives, outlook, goals, strategies,
More informationWolters Kluwer 2018 Full-Year Results
Wolters Kluwer 2018 Full-Year Results Nancy McKinstry CEO Kevin Entricken CFO February 20, 2019 2018 Full-Year Results 1 Forward-looking Statements This presentation contains forward-looking statements.
More informationInvestment Community Conference Call
DieboldNixdorf.com Investment Community Conference Call Third Quarter, 2018 Earnings October 31, 2018 Use of non-gaap Financial Information To supplement our condensed consolidated financial statements
More informationZEBRA TECHNOLOGIES. William Blair Growth Stock Conference June 16, 2016
ZEBRA TECHNOLOGIES William Blair Growth Stock Conference June 16, 2016 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements
More informationIBM 4Q 2017 Earnings. January 18, ibm.com/investor
IBM 4Q 2017 Earnings January 18, 2018 ibm.com/investor Forward Looking Statements and Non-GAAP Information 2 Certain comments made in this presentation may be characterized as forward looking under the
More informationFourth Quarter 2017 Earnings
Fourth Quarter 2017 Earnings Jeff Jacobson, CEO Bill Osbourn, CFO January 31, 2018 http://www.xerox.com/investor Cautionary Statement Regarding Forward-Looking Statements This presentation, and other written
More informationPTC PREPARED REMARKS FOURTH QUARTER AND FULL YEAR FISCAL 2017 OCTOBER 25, 2017
PTC PREPARED REMARKS FOURTH QUARTER AND FULL YEAR FISCAL 2017 OCTOBER 25, 2017 Please refer to the Important Disclosures section of these prepared remarks for important information about our operating
More informationQ Results Supplemental Presentation to Earnings Press Release May 1, 2018
Q1 2018 Results Supplemental Presentation to Earnings Press Release May 1, 2018 Forward-Looking Statements NuVasive, Inc. ( NuVasive, NUVA or the Company ) cautions you that statements included in this
More informationRelated to Forward-Looking Statements Related to Non-GAAP Financial Information
Q2 2017 Earnings Disclaimers Related to Forward-Looking Statements Certain items in this presentation and in today s discussion, including matters relating to revenue, net income (loss), and percentages
More informationB. Riley Investor Conference. May 23, 2018
B. Riley Investor Conference May 23, 2018 About This Presentation Safe Harbor Statement This presentation includes forward-looking statements (statements which are not historical facts) within the meaning
More informationQ EARNINGS CONFERENCE CALL BILL NUTI, CHAIRMAN & CEO MARK BENJAMIN, PRESIDENT & COO BOB FISHMAN, CFO
1 Q2 2017 EARNINGS CONFERENCE CALL BILL NUTI, CHAIRMAN & CEO MARK BENJAMIN, PRESIDENT & COO BOB FISHMAN, CFO July 20, 2017 NOTES TO INVESTORS FORWARD-LOOKING STATEMENTS. Comments made during this conference
More informationInvestor Presentation
Feb Investor Presentation 2018 Lee D. Rudow President and CEO Michael J. Tschiderer Chief Financial Officer NASDAQ: TRNS 1 Safe Harbor Statement This presentation contains forward looking statements within
More informationMSCI. J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO. February 28, 2017
MSCI J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO February 28, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document.
More informationPTC PREPARED REMARKS SECOND QUARTER FISCAL 2018 APRIL 18, 2018
PTC PREPARED REMARKS SECOND QUARTER FISCAL 2018 APRIL 18, 2018 Please refer to the Important Disclosures section of these prepared remarks for important information about our operating metrics (including
More information2017 THIRD QUARTER RESULTS. Ended September 30, 2017
2017 THIRD QUARTER RESULTS Ended September 30, 2017 Forward Looking Statements Disclaimer This presentation contains statements, including statements about future plans and expectations, which constitute
More informationTHIRD QUARTER 2018 EARNINGS CALL. November 6, 2018
THIRD QUARTER 2018 EARNINGS CALL November 6, 2018 1 AGENDA AND SPEAKERS Joe Woody Chief Executive Officer Progress on 2018 Priorities V NOS Outlook Steve Voskuil Chief Financial Officer Third Quarter Financial
More informationInvestor Presentation Q1 2018
Investor Presentation Q1 2018 1 Forward-looking statements Safe Harbor Statement This presentation contains forward-looking statements, which may concern our plans, objectives, outlook, goals, strategies,
More informationA Leading National Provider of Post-Acute Services
A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future
More informationFirst-Quarter 2018 Earnings
First-Quarter 208 Earnings Baxter International Inc. April 26, 208 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results, business development
More informationPTC PREPARED REMARKS THIRD QUARTER FISCAL 2018 JULY 18, 2018
PTC PREPARED REMARKS THIRD QUARTER FISCAL 2018 JULY 18, 2018 Please refer to the updated Important Disclosures section of these prepared remarks for important information about our operating metrics (including
More informationFINANCIALS VINCENT PILETTE CFO
FINANCIALS VINCENT PILETTE CFO FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of the U.S. federal securities laws, including, without limitation, statements
More informationRoyal Bank of Canada Third Quarter Results August 22, 2018
Royal Bank of Canada Third Quarter Results August 22, 2018 All amounts are in Canadian dollars unless otherwise indicated and are based on financial statements prepared in compliance with International
More informationInvestor Update Philip Mezey, President and Chief Executive Officer
Investor Update Philip Mezey, President and Chief Executive Officer Barbara Doyle, Vice President, Investor Relations March 2018 FORWARD LOOKING STATEMENTS Certain matters in this presentation and being
More informationDelivering Significant Growth. Second Quarter Fiscal 2018 Conference Call May 3, 2018
Delivering Significant Growth Second Quarter Fiscal 2018 Conference Call May 3, 2018 Preliminary Statements Forward Looking Statements This document contains certain forward-looking statements. These statements
More informationSecond Quarter 2018 Earnings Presentation May 8, 2018
Second Quarter 2018 Earnings Presentation May 8, 2018 Cautionary statements This presentation contains forward-looking statements that are subject to known and unknown risks and uncertainties, many of
More information2016 Financial Update and 2017 Outlook. Webcast Presentation December 13, 2016
2016 Financial Update and 2017 Outlook Webcast Presentation December 13, 2016 Safe Harbor Statement Note: All statements made herein that are not historical facts should be considered as forwardlooking
More informationEndo International plc
Endo International plc UBS Global Healthcare Conference May 21, 2014 Forward Looking Statements; Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of
More informationSysco Earnings Results 2Q19
Sysco Earnings Results 2Q19 FORWARD LOOKING STATEMENTS Statements made in this presentation or in our earnings call for the second quarter of fiscal 2019 that look forward in time or that express management
More informationXerox Investor Handout as of Q Third Quarter 2018 Earnings
Xerox Investor Handout as of Q4 2018 Third Quarter 2018 Earnings http://www.xerox.com/investor Forward-Looking Statements This presentation, and other written or oral statements made from time to time
More informationA Leading National Provider of Post-Acute Services
A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future
More informationMorgan Stanley 5 th Annual Laguna Conference
September 14, 2017 Morgan Stanley 5 th Annual Laguna Conference Bob Livingston President & Chief Executive Officer Forward Looking Statements This presentation may contain "forward-looking" statements
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers February 2018 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement The statements in this
More informationOur Transformation Continues. March 21, 2018
Our Transformation Continues March 21, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation, we make
More information1Q 2013 INVESTOR PRESENTATION
1Q 2013 INVESTOR PRESENTATION APRIL 2013 FORWARD-LOOKING STATEMENTS The following discussion contains forward-looking statements, including those about Nielsen s outlook and prospects, in the meaning of
More informationQ EARNINGS 8/1/2018 CONFERENCE CALL. Copyright 2017 ARRIS Enterprises, LLC. All rights reserved
Q2 2018 EARNINGS 8/1/2018 CONFERENCE CALL Copyright 2017 ARRIS Enterprises, LLC. All rights reserved Safe Harbor FORWARD-LOOKING STATEMENTS Statements made in this presentation, including those related
More informationIDEAS East Coast Conference
May 18, 2017 IDEAS East Coast Conference Lee D. Rudow President and CEO Michael J. Tschiderer Chief Financial Officer 1 Safe Harbor Statement This presentation contains forward-looking statements within
More informationNon-GAAP Reconciliation as of April 26, 2018
Non-GAAP Reconciliation as of April 26, 2018 Non-GAAP Reconciliations: As part of its Q1 2018 earnings announcement on April 26, 2018, Baxter presented historical results for Q1 2017. Baxter also presented
More informationThird Quarter Financial Results 2018
Third Quarter Financial Results 2018 October 24, 2018 Safe Harbor / Forward Looking Statements Certain statements made in this presentation are forward-looking statements within the meaning of the federal
More informationPERFORMANCE AND TRAJECTORY
PERFORMANCE AND TRAJECTORY José (Joe) E. Almeida Chairman, President and CEO May 21, 2018 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results,
More informationIBM 2Q 2018 Earnings. July 18, ibm.com/investor
IBM 2Q 2018 Earnings July 18, 2018 ibm.com/investor Forward Looking Statements and Non-GAAP Information 2 Certain comments made in this presentation may be characterized as forward looking under the Private
More informationA leading provider of post acute services
A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits
More informationRaymond James 37 th Annual Institutional Investors Conference. March 8, 2016
Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,
More informationSysco 1Q18 Earnings Results
Sysco 1Q18 Earnings Results 11.06.17 Forward-Looking Statements Statements made in this presentation or in our earnings call for the first quarter of fiscal 2018 that look forward in time or that express
More informationFourth Quarter 2018 Earnings Review
Citi Investor Relations Fourth Quarter 2018 Earnings Review January 14, 2019 Overview 4Q 18 showed continued progress in a challenging environment Continued momentum in Institutional accrual businesses
More informationSingular Best of the Uncovered 12 th Annual Conference 2017
Dec 4, 2017 Singular Best of the Uncovered 12 th Annual Conference 2017 Michael J. Tschiderer Chief Financial Officer NASDAQ: TRNS 1 Safe Harbor Statement This presentation contains forward-looking statements
More informationRogers Corporation Q Earnings Call April 27, 2017
Rogers Corporation Q1-2017 Earnings Call April 27, 2017 Forward-looking statements Safe Harbor Statement This presentation contains forward-looking statements, which may concern our plans, objectives,
More informationACXIOM ANNOUNCES SECOND QUARTER RESULTS. Connectivity Posts Record Revenue and Double-Digit Segment Margin. Strengthens Full-Year EPS Guidance
ACXIOM ANNOUNCES SECOND QUARTER RESULTS Connectivity Posts Record Revenue and Double-Digit Segment Margin Strengthens Full-Year EPS Guidance Repurchases 860,000 Shares in the Quarter CONWAY, Ark., November
More informationBusiness & Financial Model
Business & Financial Model March 6, 2014 Bracken Darrell Vincent Pilette Forward Looking Statements 2 This presentation includes forward-looking statements within the meaning of the U.S. federal securities
More informationQ4 AND FULL YEAR 2017 EARNINGS
Q4 AND FULL YEAR 2017 EARNINGS 2/14/2018 CONFERENCE CALL SAFE HARBOR FORWARD-LOOKING STATEMENTS Statements made in this presentation, including those related to revenues and net income for the first quarter
More informationXYLEM INC. Q EARNINGS RELEASE FEBRUARY 1, 2018
XYLEM INC. Q4 2017 EARNINGS RELEASE FEBRUARY 1, 2018 Q4 2017 EARNINGS RELEASE FORWARD-LOOKING STATEMENTS This presentation contains information that may constitute forward-looking statements. Forward-looking
More information3Q18 Financial Results. October 19, 2018
3Q18 Financial Results October 19, 2018 Forward-looking statements and use of key performance metrics and non-gaap financial measures This document contains forward-looking statements within the Private
More informationEarnings Presentation 2nd Quarter 2017
Earnings Presentation 2nd Quarter 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationSecond Quarter 2018 Earnings Conference Call. May 1, 2018
Second Quarter 2018 Earnings Conference Call May 1, 2018 1 Safe Harbor Statement Our commentary and responses to your questions may contain forward-looking statements, including our outlook for the remainder
More informationZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS. August 9, 2016
ZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS August 9, 2016 Anders Gustafsson Chief Executive Officer Mike Smiley Chief Financial Officer 2 Safe Harbor Statement Statements made in this presentation
More informationRent-A-Center today is
INVESTOR PRESENTATION FIRST QUARTER 2014 Safe Harbor This presentation contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements generally can be identified
More informationIBM 4Q 2018 Earnings. January 22, ibm.com/investor
IBM 4Q 2018 Earnings January 22, 2019 ibm.com/investor Forward Looking Statements and Non-GAAP Information 2 Certain comments made in this presentation may be characterized as forward looking under the
More informationGardner Denver Third Quarter 2017 Earnings Presentation. October 26, 2017
Gardner Denver Third Quarter 2017 Earnings Presentation October 26, 2017 Replay Information Dial toll-free: +1.877.344.7529 International: +1.412.317.0088 Conference ID: #10113255 Log on to: http://investors.gardnerdenver.com
More informationQ FINANCIAL RESULTS CONFERENCE CALL. Tuesday, July 24, :00 P.M. Pacific Time
Q2 2012 FINANCIAL RESULTS CONFERENCE CALL Tuesday, July 24, 2012 2:00 P.M. Pacific Time Forward Looking Statements Information, statements and projections contained in these presentation slides and related
More informationNovember 2, Third Quarter 2017 Earnings Call
November 2, 2017 Third Quarter 2017 Earnings Call Forward-looking Statements This presentation, as well as other statements made by Delphi Automotive PLC (the Company ), contain forward-looking statements
More informationDecember 5, Conduent Investor Presentation
December 5, 2016 Conduent Investor Presentation Cautionary Statements Forward-Looking Statements This presentation contains forward-looking statements that involve risks and uncertainties. These statements
More informationEarnings Presentation 4th Quarter, 2017
Earnings Presentation 4th Quarter, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More information